BNC KOREA, Inc. (KOSDAQ:256840)
South Korea · Delayed Price · Currency is KRW 2,660.00
+40.00 (1.53%)
Sep 4, 2026, 3:30 PM KST
BNC KOREA Market Cap
BNC KOREA has a market cap or net worth of 181.93 billion as of September 4, 2026. Its market cap has decreased by -45.44% in one year.
Market Cap
181.93B
Enterprise Value
117.45B
Revenue
91.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,660.00
ChartMarket Cap Chart
Since December 28, 2016, BNC KOREA's market cap has increased from 11.35B to 181.93B, an increase of 1,503.31%. That is a compound annual growth rate of 33.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 181.93B | -40.63% |
| Dec 30, 2025 | 306.41B | 11.12% |
| Dec 30, 2024 | 275.74B | 12.30% |
| Dec 28, 2023 | 245.55B | -20.03% |
| Dec 29, 2022 | 307.06B | -78.68% |
| Dec 30, 2021 | 1.44T | 557.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yungjin Pharm. | 203.38B |
| Whan In Pharm | 191.49B |
| Chong Kun Dang Holdings | 185.19B |
| REYON Pharmaceutical | 182.86B |
| FutureChem Co.,Ltd | 182.29B |
| AptaBio Therapeutics | 181.48B |
| JW Lifescience | 174.36B |
| Daewon Pharmaceutical | 171.25B |